IN8BIO INC's ticker is and the CUSIP is 45674E109. A total of 27 filers reported holding IN8BIO INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,205,329 | -28.3% | 1,423,897 | 0.0% | 0.00% | – |
| Q1 2024 | $1,680,198 | +192.2% | 1,423,897 | +241.7% | 0.00% | – |
| Q4 2023 | $575,040 | +63.2% | 416,696 | +23.0% | 0.00% | – |
| Q3 2023 | $352,277 | -20.5% | 338,728 | +17.8% | 0.00% | – |
| Q2 2023 | $442,853 | +62.2% | 287,567 | +36.9% | 0.00% | – |
| Q1 2023 | $273,091 | -29.9% | 210,070 | +24.6% | 0.00% | – |
| Q4 2022 | $389,595 | +13.9% | 168,656 | -0.5% | 0.00% | – |
| Q3 2022 | $342,000 | +36.8% | 169,528 | +53.1% | 0.00% | – |
| Q2 2022 | $250,000 | -32.8% | 110,695 | -0.7% | 0.00% | – |
| Q1 2022 | $372,000 | -29.5% | 111,493 | -7.3% | 0.00% | – |
| Q4 2021 | $528,000 | -31.9% | 120,216 | +6.3% | 0.00% | – |
| Q3 2021 | $775,000 | – | 113,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRECEPT MANAGEMENT LLC | 50,000 | $101,000 | 0.72% |
| Voss Capital, LP | 375,570 | $759,000 | 0.22% |
| Stonegate Investment Group, LLC | 232,310 | $469,000 | 0.02% |
| Sigma Planning Corp | 98,750 | $199,000 | 0.01% |
| Warberg Asset Management LLC | 15,000 | $30,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 74,000 | $149,000 | 0.00% |
| United Asset Strategies, Inc. | 14,000 | $28,000 | 0.00% |
| Ensign Peak Advisors, Inc | 70,028 | $141,000 | 0.00% |
| HighTower Advisors, LLC | 14,164 | $28,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,821 | $4,000 | 0.00% |